{"transactions":[{"id":939230,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-14T23:02:48.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":25856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":279931,"derivative":{"underlying":"Common Stock","underlying_shares":25856},"source":{"system":"sec-edgar","filing":"0001437749-26-001286","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001286/rdgdoc.xml","form_type":"4"}},{"id":939229,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-14T23:02:48.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":40655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030."}],"balance_after":254075,"derivative":{"exercise_price":15.47,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":40655},"source":{"system":"sec-edgar","filing":"0001437749-26-001286","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001286/rdgdoc.xml","form_type":"4"}},{"id":939228,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-14T23:02:48.000Z","date":"2026-01-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2293,"price":15.47,"value":35472.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $15.46 to $15.48. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":213420,"source":{"system":"sec-edgar","filing":"0001437749-26-001286","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001286/rdgdoc.xml","form_type":"4"}},{"id":971256,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-12T21:55:46.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":5502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest immediately as of the award date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest immediately as of the award date."}],"balance_after":210255,"derivative":{"underlying":"Common Stock","underlying_shares":5502},"source":{"system":"sec-edgar","filing":"0001437749-25-037743","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925037743/rdgdoc.xml","form_type":"4"}},{"id":971255,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T21:55:46.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":4542,"price":16.99,"value":77168.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $16.94 to $17.07. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":215713,"source":{"system":"sec-edgar","filing":"0001437749-25-037743","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925037743/rdgdoc.xml","form_type":"4"}},{"id":1060326,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:14:03.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":2631,"price":16.02,"value":42148.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":204753,"source":{"system":"sec-edgar","filing":"0001437749-25-027464","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925027464/rdgdoc.xml","form_type":"4"}},{"id":1060325,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:14:03.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":39082,"price":16.16,"value":631565.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":205299,"source":{"system":"sec-edgar","filing":"0001437749-25-027464","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925027464/rdgdoc.xml","form_type":"4"}},{"id":1310758,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-06T21:15:21.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":25876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":25876,"derivative":{"underlying":"Common Stock","underlying_shares":25876},"source":{"system":"sec-edgar","filing":"0001437749-25-000452","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925000452/rdgdoc.xml","form_type":"4"}},{"id":1310757,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-06T21:15:21.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":38621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029."}],"balance_after":38621,"derivative":{"exercise_price":13,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":38621},"source":{"system":"sec-edgar","filing":"0001437749-25-000452","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925000452/rdgdoc.xml","form_type":"4"}},{"id":1641008,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-15T21:21:05.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":144677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028."}],"balance_after":374763,"derivative":{"exercise_price":4.42,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":144677},"source":{"system":"sec-edgar","filing":"0001437749-24-004369","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774924004369/rdgdoc.xml","form_type":"4"}},{"id":1973883,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T21:10:15.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":100086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027."}],"balance_after":200086,"derivative":{"exercise_price":3.47,"expiration_date":"2033-02-19","underlying":"Common Stock","underlying_shares":100086},"source":{"system":"sec-edgar","filing":"0001493152-23-006672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315223006672/ownership.xml","form_type":"4"}},{"id":2206327,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":69392,"kind":"person","name":"Gruber James R.","position":1,"cik":"0001923165","reported_name":"Gruber James R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-18T20:32:47.000Z","date":"2022-07-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-019653","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315222019653/ownership.xml","form_type":"4"}}]}